Investor Relations
Financial Performance & Metrics
Comprehensive financial data, segment breakdowns, and operational highlights for Aevum Zenth Conglomerate (FY2021–FY2025).
Total Revenue
$0B
▲ 12.4% YoY
EBITDA
$0B
▲ 9.1% YoY
Net Income
$0B
▲ 14.2% YoY
Free Cash Flow
$0B
▲ 8.7% YoY
R&D Expenditure
$0B
▲ 18.5% YoY
Employees
0K
▲ 6.2% Growth
Annual Performance Summary
| Fiscal Year | Revenue | Net Income | EBITDA | Margin | EPS |
|---|---|---|---|---|---|
| FY 2021 | $61.4B | $11.2B | $18.9B | 18.2% | $0.64 |
| FY 2022 | $68.9B | $12.8B | $20.4B | 18.6% | $0.71 |
| FY 2023 | $74.6B | $14.1B | $22.1B | 18.9% | $0.79 |
| FY 2024 | $83.8B | $16.5B | $25.3B | 19.7% | $0.88 |
| FY 2025 | $94.2B | $18.9B | $28.7B | 20.1% | $0.98 |
Revenue by Segment (FY2025)
Digital Systems & Tech31.2%
Energy & Power24.1%
Health Sciences18.4%
Aerospace & Defense14.8%
Capital Group & Real Estate11.5%
Quarterly Earnings Trend (FY2025)
Investor Metrics
Ticker
AZTH
NYSE / Euronext
Market Capitalization
$312.4B
USD (As of 12/31/2025)
P/E Ratio (TTM)
16.5
Industry Avg: 19.2
Dividend Yield
2.8%
Quarterly Payout: $0.07
52-Week Range
$142.10 – $189.50
Current: $168.25
Beta
0.82
Lower volatility vs market
Forward-Looking Statements & Disclaimer: This page contains historical financial data and projected metrics for informational purposes only. Actual results may differ due to market conditions, regulatory changes, and operational variables. Aevum Zenth Conglomerate does not guarantee future performance. For official SEC filings, audited reports, and regulatory disclosures, please visit our Investor Relations portal. Data as of Q4 FY2025 earnings release. All figures in USD unless otherwise noted.